Hematological Malignancy Patients, COVID-19, and Favipiravir

Hematological Malignancy Patients, COVID-19, and Favipiravir [Turk J Hematol]

Rujittika Mungmunpuntipantip¹, Viroj Wiwanitkit²
¹Private Academic Consultant, Bangkok, Thailand
²D.Y. Patil University, Pune, India

Keywords: Malignancy, COVID-19, Favipiravir

Hematolojik Malignite Hastaları, COVID-19 ve Favipiravir

Rujittika Mungmunpuntipantip¹, Viroj Wiwanitkit²
¹Private Academic Consultant, Bangkok, Thailand
²D.Y. Patil University, Pune, India

Anahtar Kelimeler: COVID-19, Favipiravir

Corresponding Author: Rujittika Mungmunpuntipantip, Thailand
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar